An Analytical Method to Monitor Dietary Fat Intake
|
By LabMedica International staff writers Posted on 25 May 2020 |

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.
Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.
The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.
For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.
Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.
In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.
"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"
The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.
Related Links:
McMaster University
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








